Exhibit 14(f)
July 27, 2018
Independent Directors Committee of the Board of Directors
Corporate Capital Trust, Inc.
201 Rouse Boulevard
Philadelphia, PA 19112
Members of the Committee:
We hereby consent to the inclusion of our opinion letter, dated July 22, 2018, to the Independent Directors Committee of the Board of Directors (the “Committee”) of Corporate Capital Trust, Inc. (“CCT”) as Annex C to, and to the reference thereto under the headings “SUMMARY OF THE MERGER — Reasons for the Merger”, “THE MERGER – Background of the Merger”, “THE MERGER — Reasons for the Merger” and “THE MERGER — Opinion of CCT Independent Director Committee’s Financial Advisor” in, the joint proxy statement/prospectus relating to the proposed merger involving CCT and FS Investment Corporation (“FSIC”), which joint proxy statement/prospectus forms a part of FSIC’s Registration Statement on Form N-14 to which this consent is filed as an exhibit. In giving the foregoing consent, we do not admit (1) that we come within the category of persons whose consent is required under Section 7 of the Securities Act of 1933, as amended (the “Securities Act”), or the rules and regulations of the Securities and Exchange Commission (the “Commission”) promulgated thereunder, or (2) that we are experts with respect to any part of the Registration Statement within the meaning of the term “experts” as used in the Securities Act and the rules and regulations of the Commission promulgated thereunder.
Very truly yours,
/s/ Merrill Lynch, Pierce, Fenner & Smith Incorporated
MERRILL LYNCH, PIERCE, FENNER & SMITH
INCORPORATED